Mesenchymal stem cells and cardiac repair

被引：90

作者：

Nesselmann, Catharina ^{[1
]}

Ma, Nan ^{[1
]}

Bieback, Karen ^{[2
]}

Wagner, Wolfgang ^{[3
]}

Ho, Anthony ^{[3
]}

Konttinen, Yrjo T. ^{[4
]}

Zhang, Hao ^{[5
,6
]}

Hinescu, Mihail E. ^{[7
,8
]}

Steinhoff, Gustav ^{[1
]}

机构：

[1] Univ Rostock, Dept Cardiac Surg, D-18057 Rostock, Germany

[2] Heidelberg Univ, Inst Transfus Med & Immunol, Med Fac Mannheim, German Red Cross Blood Donor Serv Baden Wurttembe, D-6900 Heidelberg, Germany

[3] Heidelberg Univ, Med Klin 5, D-6900 Heidelberg, Germany

[4] Biomedicum Helsinki, Helsinki, Finland

[5] Chinese Acad Med Sci, Cardiovasc Inst, Beijing, Peoples R China

[6] Chinese Acad Med Sci, Fuwai Hosp, Beijing, Peoples R China

[7] Carol Davila Univ Med & Pharm, Dept Cellular & Mol Med, Bucharest, Romania

[8] Victor Babes Natl Inst Pathol, Bucharest, Romania

来源：

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | 2008年 / 12卷 / 5B期

关键词：

mesenchymal stem cells; ICLCs; regenerative medicine; heart muscle; repair mechanisms; ex vivo cell manipulation;

D O I：

10.1111/j.1582-4934.2008.00457.x

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Accumulating clinical and experimental evidence indicates that mesenchymal stem cells (MSCs) are promising cell types in the treatment of cardiac dysfunction. They may trigger production of reparative growth factors, replace damaged cells and create an environment that favours endogenous cardiac repair. However, identifying mechanisms which regulate the role of MSCs in cardiac repair is still at work. To achieve the maximal clinical benefits, ex vivo manipulation can further enhance MSC therapeutic potential. This review focuses on the mechanism of MSCs in cardiac repair, with emphasis on ex vivo manipulation.

引用

页码：1795 / 1810

页数：16

共 138 条

[31] Immortalized multipotential mesenchymal cells and the hematopoietic microenvironment [J].

Dormady, SP ;

Bashayan, O ;

Dougherty, R ;

Zhang, XM ;

Basch, RS .

JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2001, 10 (01) :125-140

[32]

Faussone-Pellegrini Maria Simonetta, 2005, Italian Journal of Anatomy and Embryology, V110, P11

[33]

Faussone-Pellegrini MS, 1999, MICROSC RES TECHNIQ, V47, P248, DOI 10.1002/(SICI)1097-0029(19991115)47:4<248::AID-JEMT4>3.0.CO

[34]

2-W

[35] Hepatocyte growth factor effects on mesenchymal stem cells: Proliferation, migration, and differentiation [J].

Forte, G ;

Minieri, M ;

Cossa, P ;

Antenucci, D ;

Sala, M ;

Gnocchi, V ;

Fiaccavento, R ;

Carotenuto, F ;

De Vito, P ;

Baldini, PM ;

Prat, M ;

Di Nardo, P .

STEM CELLS, 2006, 24 (01) :23-33

[36] Recent advances into the understanding of mesenchymal stem cell trafficking [J].

Fox, James M. ;

Chamberlain, Giselle ;

Ashton, Brian A. ;

Middleton, Jim .

BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (06) :491-502

[37] A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction [J].

Freyman, T ;

Polin, G ;

Osman, H ;

Crary, J ;

Lu, MM ;

Cheng, L ;

Palasis, M ;

Wilensky, RL .

EUROPEAN HEART JOURNAL, 2006, 27 (09) :1114-1122

[38]

FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381

[39] Phosphatidylinositol 3-kinase regulates bone morphogenetic protein-2 (BMP-2)-induced myocyte enhancer factor 2A-dependent transcription of BMP-2 gene in cardiomyocyte precursor cells [J].

Ghosh-Choudhury, NG ;

Abboud, SL ;

Mahimainathan, L ;

Chandrasekar, B ;

Choudhury, GG .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (24) :21998-22005

[40] From the laboratory bench to the patients bedside: An update on clinical trials with mesenchymal stem cells [J].

Giordano, Antonio ;

Galderisi, Umberto ;

Marino, Ignazio R. .

JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 211 (01) :27-35

← 1 2 3 4 5 6 7 8 9 10 →